In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycin
- 1 February 1997
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 16 (2) , 155-158
- https://doi.org/10.1007/bf01709476
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogensAntimicrobial Agents and Chemotherapy, 1995
- Quinupristin/Dalfopristin: Spectrum of Activity, Pharmacokinetics, and Initial Clinical ExperienceMicrobial Drug Resistance, 1995
- In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC of the components of a semisynthetic streptogramin, RP 59500Journal of Antimicrobial Chemotherapy, 1992
- Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococi with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibioticsJournal of Antimicrobial Chemotherapy, 1992